Latest news
CHRS: LOQTORZI sales rose 15% in Q2, with key clinical data readouts expected later in 2026 - TradingViewTradingView · Wed, 05 Aug 2026 23:23:51 GMTCoherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 23:10:25 GMTCHRS: Q2 2026 revenue rose 40% year-over-year, but ongoing losses and funding needs persist - TradingViewTradingView · Wed, 05 Aug 2026 21:15:06 GMTCHRS: Q2 2026 revenue up 39% year-over-year, net loss narrows, and pipeline advances continue - TradingViewTradingView · Wed, 05 Aug 2026 20:30:16 GMTCHRS Q2'26 Earnings: EPS estimate is (0.24) USD - TradingViewTradingView · Tue, 04 Aug 2026 11:01:32 GMT